Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation

被引:85
|
作者
Yang, Chunguang [1 ]
Ma, Xueyou [1 ]
Wang, Zhihua [1 ]
Zeng, Xing [1 ]
Hu, Zhiquan [1 ]
Ye, Zhangqun [1 ]
Shen, Guanxin [2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan, Hubei, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
curcumin; castration-resistant prostate cancer; apoptosis; autophagy; iron chelation; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; HEPATOMA; EFFICACY; THERAPY;
D O I
10.2147/DDDT.S126964
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Curcumin induces apoptosis and autophagy in different cancer cells. Moreover, chemical and biological experiments have evidenced that curcumin is a biologically active iron chelator and induces cytotoxicity through iron chelation. We thus hypothesized that curcumin may induce apoptosis and autophagy in castration-resistant prostate cancer (CRPC) cells through its iron-chelating properties. Materials and methods: CRPC cells were loaded with curcumin alone or in combination with ferric ammonium citrate (FAC). Cytotoxicity was measured by 3-(4,5-dimethylthiazol2- yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis was assessed by flow cytometry, terminal deoxynucleotidyl transferase nick end labeling (TUNEL) assay and caspase activity. Autophagy status was analyzed by the detection of autophagosomes and light chain 3-II (LC3-II) using transmission electron microscopy and Western blot. Iron-binding activity of curcumin was assessed by spectrophotometry and MTT assay. The expression levels of transferrin receptor 1 (TfR1) and iron regulatory protein 1 (IRP1) were examined by Western blot. Results: Curcumin induced apoptosis and autophagy in CRPC cells. Combining curcumin with autophagy inhibitors (3-methyladenine [3-MA]) synergized the apoptotic effect of curcumin. Moreover, curcumin bound to FAC at a ratio of similar to 1: 1, as assessed by spectrophotometry and MTT assay. Apoptosis and autophagy induced by curcumin were counteracted by equal amounts of FAC. At apoptosis-and autophagy-inducing concentrations, curcumin enhanced the expression levels of TfR1 and IRP1, indicative of iron deprivation induced by curcumin. Conclusion: Together, our results indicate that curcumin induces apoptosis and protective autophagy in CRPC cells, which are at least partially dependent on its iron-chelating properties.
引用
收藏
页码:431 / 439
页数:9
相关论文
共 50 条
  • [41] Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy
    Liu, Jiangfei
    Ni, Yaohui
    Zhou, Keyun
    Wu, Guanzhao
    Hu, Liangyong
    Zhu, Tianyu
    Xu, Defeng
    Hu, Hang
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 104 (01)
  • [42] Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo
    Mapoung, Sariya
    Suzuki, Shugo
    Fuji, Satoshi
    Naiki-Ito, Aya
    Kato, Hiroyuki
    Yodkeeree, Supachai
    Ovatlarnporn, Chitchamai
    Takahashi, Satoru
    Limtrakul , Pornngarm
    CANCER SCIENCE, 2019, 110 (02) : 596 - 607
  • [43] YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells
    Sheng, Xia
    Li, Wen-Bin
    Wang, De-Lin
    Chen, Ke-Hong
    Cao, Jian-Jia
    Luo, Zhao
    He, Jiang
    Li, Mei-Cai
    Liu, Wu-Jiang
    Yu, Chao
    MOLECULAR MEDICINE REPORTS, 2015, 12 (04) : 4867 - 4876
  • [44] Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
    Wang, Jinxiang
    Zeng, Leli
    Wu, Nisha
    Liang, Yanling
    Jin, Jie
    Fan, Mingming
    Lai, Xiaoju
    Chen, Zhe-Sheng
    Pan, Yihang
    Zeng, Fangyin
    Deng, Fan
    DRUG RESISTANCE UPDATES, 2023, 70
  • [45] The DNA methylome of castration-resistant prostate cancer
    Kleb, Brittney N.
    Estecio, Marcos
    Zhang, Jiexin
    Tzelepi, Vasso
    Chung, Woonbok
    Maity, Sankar
    Logothetis, Christopher
    Troncoso, Patricia
    Navone, Nora
    Jelinek, Jaroslav
    Liang, Shoudan
    Issa, Jean-Pierre
    Aparicio, Ana
    CANCER RESEARCH, 2012, 72
  • [46] Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Biswas, Bivas
    Ganguly, Sandip
    Ghosh, Joydeep
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1174 - 1175
  • [47] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [48] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [49] Castration-Resistant Prostate Cancer: AUA Guideline
    Cookson, Michael S.
    Roth, Bruce J.
    Dahm, Philipp
    Engstrom, Christine
    Freedland, Stephen J.
    Hussain, Maha
    Lin, Daniel W.
    Lowrance, William T.
    Murad, Mohammad Hassan
    Oh, William K.
    Penson, David F.
    Kibel, Adam S.
    JOURNAL OF UROLOGY, 2013, 190 (02): : 429 - 438
  • [50] Enzalutamide in Castration-Resistant Prostate Cancer Reply
    Hussain, Maha
    Saad, Fred
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1381 - 1381